CNGE Conseil
Paris, 75011, France
NCT Number: NCT06854965
This research focuses on identifying medical, social, and healthcare journey determinants associated with the evolution of quality of life in the transgender population at 12 months. To address the research question, it is planned to include 1,500 transgender individuals, among those attending healthcare professionals or associations in the French territory who have agreed to take on the role of investigators (professionals in healthcare or designated individuals within an association).
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Paris, 75011, France
Information Note:
In the framework of this research, an initial questionnaire will be administered at time T0, during participants appointment (either via video call or in person) with a health mediator. A second questionnaire will be administered 6 months later during a second appointment (via video call or in person) with a health mediator. Finally, a third and final questionnaire will be administered 12 months after T0 during a final appointment (via video call or in person) with a health mediator. The aim of these various questionnaires is to assess the evolution of quality of life over a period of 12 months. Each questionnaire will take a maximum of 40 minutes to complete.
The maximum time between the presentation of the information note and the contact by the health mediator is 1 month.
If there is a need to travel to complete the questionnaires in person, the travel expenses will be covered by the sponsor.
This processing is necessary for conducting the research which serves the public interest mission entrusted to CNGE Conseil.
For this purpose, participants medical data and data regarding participants lifestyle habits, as well as ethnic origins or data relating to sexual life, will be transmitted to the Sponsor or to individuals or companies acting on its behalf, in France. This data will be identified by a participants data may be used for subsequent research or additional analyses related to this research in collaboration with private or public partners, in France or abroad, under conditions ensuring their confidentiality and the same level of protection as European legislation. Participants may oppose at any time to the subsequent use of participants data by contacting the qualified person who proposed participation in this research project. Participants data will be retained only for the period strictly necessary and proportionate to the purpose of the research. They will be kept in the information systems of the data controller for up to two years after the last publication of the research results.
Participants data will then be archived in accordance with applicable regulations (article R1123-63 of the French Public Health Code). The archiving of research documents will be for a minimum of 15 years.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From enrollment to the last questionnaire at 12 months
Differences in the WHOQOL-BREF between 0 and 12 months. The WHOQOL-BREF (World Health Organization Quality Of Life tool) consists of four dimensions: physical health, psychological health, social relationships and environment, with scores ranging from 0 to 100. A higher score denotes a higher quality of life.
Time frame: Baseline and 6 months
WHOQOL-BREF at baseline and 6 months. The WHOQOL-BREF (World Health Organization Quality Of Life tool) consists of four dimensions: physical health, psychological health, social relationships and environment, with scores ranging from 0 to 100. A higher score denotes a higher quality of life.
Time frame: From baseline to 6 months
Differences in WHOQOL-BREF between 0 and 6 months. The WHOQOL-BREF (World Health Organization Quality Of Life tool) consists of four dimensions: physical health, psychological health, social relationships and environment, with scores ranging from 0 to 100. A higher score denotes a higher quality of life.
Time frame: Baseline
Mental health assessed with MHC-SF tool
Time frame: Baseline
Sexual health defined by history of STIs and unprotected sexual intercourse
Time frame: Baseline
Addictions assessed with ASSIST tool
Time frame: Baseline
Participation in organized screenings for breast cancer, cervical cancer and colorectal cancer and individual screenings of STI
Time frame: Baseline
Complications related to hormone therapy or transition surgery
Time frame: Baseline
Presence of comorbidities (cardiovascular diseases, cardiovascular risk factors, various pathologies, etc.)
Time frame: Baseline
Types of violence experienced (verbal, physical, sexual, psychological, economic)
Time frame: At baseline, 6 months and 12 months
Transition modalities (social transition, hormone therapy, surgery)
Time frame: At baseline, 6 months and 12 months
Healthcare professionals consulted
Time frame: At baseline, 6 months and 12 months
Use of self-medication in the context of hormone therapy
Contact information is provided by the study sponsor or research team.
CNGE Conseil
Other
Acronym: TRANSPOSE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05927350
Transgender Persons
Richmond, Virginia, United States
View Trial DetailsNCT07675564
Clinical Decision-making, Gender Identity
Santa Maria, Rio Grande do Sul, Brazil
View Trial DetailsNCT05116293
Transgender Persons
Seattle, Washington, United States
View Trial DetailsNCT06565663
Behavior, Gender Dysphoria
Hanover, New Hampshire, United States
View Trial Details